A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
INTRODUCTION Review question / Objective: The aim of this meta-analysis is to investigate the immune-related adverse events via anti-P ro g r a m m e d D e a t h 1 t re a t m e n t i n malignant tumors. Condition being studied: Due to the significant impact of anti-PD-1 treatment on improving the survival of several advanced cancers, the use of it will be inevitably increased in the future. It is imperative to identify the incidence and characteristics of irAEs in malignant tumors afterdoi:10.37766/inplasy2021.1.0091 fatcat:5254sle26bh2ngamh7hwlyo6s4